![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A01N 57/00 | (2006.01) |
A61K 31/675 | (2006.01) | ||
C07D 403/14 | (2006.01) | ||
C07D 405/14 | (2006.01) | ||
C07D 417/14 | (2006.01) | ||
C07D 413/14 | (2006.01) | ||
C07D 471/04 | (2006.01) |
(11) | Number of the document | 2373172 |
(13) | Kind of document | T |
(96) | European patent application number | 09831077.4 |
Date of filing the European patent application | 2009-12-02 | |
(97) | Date of publication of the European application | 2011-10-12 |
(45) | Date of publication and mention of the grant of the patent | 2013-07-17 |
(46) | Date of publication of the claims translation | 2013-12-27 |
(86) | Number | PCT/US2009/066459 |
Date | 2009-12-02 |
(87) | Number | WO 2010/065674 |
Date | 2010-06-10 |
(30) | Number | Date | Country code |
182958 P | 2009-06-01 | US | |
119723 P | 2008-12-03 | US | |
173590 P | 2009-04-28 | US | |
214881 P | 2009-04-28 | US | |
182952 P | 2009-06-01 | US |
(72) |
ZHONG, Min, US
LI, Leping, US
|
(73) |
Presidio Pharmaceuticals, Inc.,
1700 Owens Street Suite 585, San Francisco, CA 94158,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | HCV NS5A inhibitoriai |
INHIBITORS OF HCV NS5A |
Payment date | Validity (years) | Amount | |
2021-11-24 | 13 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2022-12-02 |